Aisling Capital Management LP Long-Term Concentrated

CIK: 0001766721 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 12, 2025

Total Value ($000): $456,447 (100.0% shares, 0.0% debt)

Holdings (14)

BBIO BridgeBio Pharma Inc. (BBIO) 69.3%

Value ($000) $316,294 Shares 6,089,611 Est. Cost $40.43 Unrealized +20.6%

— Verona Pharma plc (VRNA) 14.4%

Value ($000) $65,664 Shares 615,352 Est. Cost $7.38 Unrealized —

SNDX Syndax Pharmaceuticals, Inc. (SNDX) 4.4%

Value ($000) $20,266 Shares 1,316,806 Est. Cost $10.41 Unrealized +25.7%

NUVB Nuvation Bio Inc. (NUVB) 2.4%

Value ($000) $10,954 Shares 2,960,659 Est. Cost $9.98 Unrealized -72.7%

GLUE Monte Rosa Therapeutics Inc (GLUE) 2.4%

Value ($000) $10,910 Shares 1,472,331 Est. Cost $20.37 Unrealized -74.0%

BCAX Bicara Therapeutics Inc. (BCAX) 2.0%

Value ($000) $8,983 Shares 568,919 Est. Cost $25.50 Unrealized -56.1%

CMPS Compass Pathways Plc (CMPS) 1.5%

Value ($000) $6,867 Shares 1,198,418 Est. Cost $6.51 Unrealized —

BBOT BridgeBio Oncology Therapeutics (BBOT) 1.4%

Value ($000) $6,538 Shares 564,625 Est. Cost $11.58 Unrealized —

BMEA Biomea Fusion Inc (BMEA) 0.9%

Value ($000) $4,138 Shares 2,048,757 Est. Cost $8.06 Unrealized -77.3%

SRRK Scholar Rock Holding Corporation (SRRK) 0.6%

Value ($000) $2,869 Shares 77,031 Est. Cost $34.98 Unrealized 0.0%

CALC CalciMedica, Inc. (CALC) 0.4%

Value ($000) $1,603 Shares 521,114 Est. Cost $4.55 Unrealized -36.8%

ACRS Aclaris Therapeutics Inc (ACRS) 0.2%

Value ($000) $825 Shares 434,455 Est. Cost $10.31 Unrealized -83.1%

MRKR Marker Therapeutics, Inc. (MRKR) 0.1%

Value ($000) $290 Shares 325,370 Est. Cost $1.80 Unrealized -31.4%

OKUR OnKure Therapeutics, Inc. (OKUR) 0.1%

Value ($000) $244 Shares 88,607 Est. Cost $15.14 Unrealized -83.6%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
BBIO	BridgeBio Pharma Inc. (BBIO)	6,089,611	$316,294	69.3%	$40.43	+20.6%	COM	10806X102
—	Verona Pharma plc (VRNA)	615,352	$65,664	14.4%	$7.38	—	SPONSORED ADS	925050106
SNDX	Syndax Pharmaceuticals, Inc. (SNDX)	1,316,806	$20,266	4.4%	$10.41	+25.7%	COM	87164F105
NUVB	Nuvation Bio Inc. (NUVB)	2,960,659	$10,954	2.4%	$9.98	-72.7%	COM CL A	67080N101
GLUE	Monte Rosa Therapeutics Inc (GLUE)	1,472,331	$10,910	2.4%	$20.37	-74.0%	COM	61225M102
BCAX	Bicara Therapeutics Inc. (BCAX)	568,919	$8,983	2.0%	$25.50	-56.1%	COM	055477103
CMPS	Compass Pathways Plc (CMPS)	1,198,418	$6,867	1.5%	$6.51	—	SPONSORED ADS	20451W101
BBOT	BridgeBio Oncology Therapeutics (BBOT)	564,625	$6,538	1.4%	$11.58	—	COM NEW	107924102
BMEA	Biomea Fusion Inc (BMEA)	2,048,757	$4,138	0.9%	$8.06	-77.3%	COM	09077A106
SRRK	Scholar Rock Holding Corporation (SRRK)	77,031	$2,869	0.6%	$34.98	0.0%	COM	80706P103
CALC	CalciMedica, Inc. (CALC)	521,114	$1,603	0.4%	$4.55	-36.8%	COM NEW	38942Q202
ACRS	Aclaris Therapeutics Inc (ACRS)	434,455	$825	0.2%	$10.31	-83.1%	COM	00461U105
MRKR	Marker Therapeutics, Inc. (MRKR)	325,370	$290	0.1%	$1.80	-31.4%	COM NEW	57055L206
OKUR	OnKure Therapeutics, Inc. (OKUR)	88,607	$244	0.1%	$15.14	-83.6%	COM CL A	68277Q105